Skip to main content
Euromedis Groupe logo

Euromedis Groupe — Investor Relations & Filings

Ticker · ALEMG ISIN · FR0000075343 LEI · 9695004RFDS89YEZN363 PA Human health and social work activities
Open in API
Filings indexed 192 across all filing types
Latest filing 2020-07-06 AGM Information
Country FR France
Listing PA ALEMG

About Euromedis Groupe

https://www.euromedis.fr

Euromedis Groupe specializes in the design, manufacturing, distribution, and rental of medical equipment and single-use devices. The company's product portfolio includes sterile and non-sterile medical gloves, dressings, compresses, diagnostics, and various hygiene-related products. It also provides solutions for the home care market, such as oxygen therapy and incontinence products. Euromedis Groupe serves a diverse client base, including hospitals, clinics, and other healthcare professionals, distributing products under its own brand name.

Recent filings

Filing Released Lang Actions
EUROMEDMIS : Annonce son transfert vers Euronext Growth
AGM Information Classification · 1% confidence The document is a press release dated July 6, 2020, announcing that the Shareholders' General Meeting (held July 3, 2020) approved the transfer of the company's listing from the regulated market Euronext Paris to Euronext Growth Paris. This involves changes in regulatory obligations, accounting standards (moving away from IFRS), and a change in the stock ticker. While it mentions the AGM approval, the core subject is a significant corporate action related to market listing and capital structure change, rather than a standard periodic financial report (like 10-K or IR) or a specific management/board change. The closest fit among the provided codes is 'Capital/Financing Update' (CAP) because changing listing markets is a fundamental capital structure/financing decision, or potentially 'Regulatory Filings' (RNS) as a general announcement. However, since the primary focus is the market transfer and its implications for listing rules and accounting standards, 'CAP' is a strong candidate. Given the context of changing listing venue and associated regulatory/financial implications, 'CAP' (Capital/Financing Update) is the most appropriate classification for a major structural change affecting how the company accesses capital markets, even though it's not a direct fundraising announcement.
2020-07-06 French
EUROMEDIS : Avis de convocation à l'AGM du 3 juillet 2020
AGM Information Classification · 1% confidence The document is titled "Avis de réunion valant avis de convocation de l'Assemblée Générale Mixte du 3 juillet 2020" (Notice of meeting serving as notice of convocation for the Combined General Meeting of July 3, 2020). It explicitly lists an 'Ordre du jour' (Agenda) covering both ordinary and extraordinary resolutions, including the approval of 2019 financial statements and various capital structure authorizations. This content is characteristic of the preparatory materials sent to shareholders before a General Meeting to inform them and solicit their votes. This aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). Although it discusses AGM matters, the document itself is the formal notice/agenda, not the final voting results (DVA) or the AGM presentation itself (AGM-R).
2020-05-29 French
EUROMEDIS GROUPE : Chiffre d'affaires 2019
Earnings Release Classification · 1% confidence The document is a "COMMUNIQUE DE PRESSE" (Press Release) dated February 13, 2020, detailing the "Chiffre d'Affaires 2019" (2019 Revenue) and providing commentary on business segments and future outlook. It presents key financial figures for the full year 2019 and compares them to 2018. This format, focusing on preliminary or key financial highlights for a period (in this case, the full year, but released before the final audited report), strongly aligns with an Earnings Release (ER). Although it covers the full year, it is a press release summarizing results, not the comprehensive 10-K. The document explicitly mentions the upcoming communication of 'Résultats annuels de l'exercice 2019' on April 22, 2020, confirming this document is the preliminary announcement of results. It is not a 10-K (Annual Report) because the 10-K is scheduled for a later date and this is a press release. It is not an Interim Report (IR) as it covers the full fiscal year. It is not an RPA because it contains substantial financial data and analysis, not just an announcement of a report's publication. FY 2019
2020-02-13 French
EUROMEDIS GROUPE : Confirmation éligibilité PEA PME
Regulatory Filings Classification · 1% confidence The document is a short press release dated February 7, 2020, titled "Confirmation éligibilité PEA PME" (Confirmation of PEA PME eligibility). It confirms that the company meets the criteria for inclusion in the French PEA-PME investment plan based on its 2018 annual accounts. This is a specific corporate announcement regarding regulatory/investment status, not a full financial report (like 10-K or IR), an earnings release (ER), or a management discussion (MDA). It is a specific regulatory/corporate update that doesn't fit perfectly into the main categories like DIV, DIRS, or CAP. Given its nature as a specific corporate status confirmation, it is best classified as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) due to the link to an investment vehicle. However, since it is a direct announcement about meeting criteria for a specific regulated investment scheme, RNS serves as the most appropriate general regulatory announcement fallback, as it is not a standard financial report or a specific event announcement like a dividend or management change. Given the short length and announcement nature, RNS is the most suitable general category.
2020-02-07 French
EUROMEDIS : Rapport complémentaire des CAC sur l'émission d'OC
Audit Report / Information Classification · 1% confidence The document is titled "RAPPORT COMPLEMENTAIRE DES COMMISSAIRES AUX COMPTES SUR L'ÉMISSION DE VALEURS MOBILIÈRES AVEC MAINTIEN DU DROIT PRÉFÉRENTIEL DE SOUSCRIPTION" (Supplementary Report of the Statutory Auditors on the Issuance of Securities with Maintenance of Preferential Subscription Rights). This clearly indicates it is a formal report issued by external auditors (Commissaires aux Comptes) concerning a specific corporate action, namely the issuance of securities (convertible bonds) under a shareholder mandate. This falls under the scope of an Audit Report or Information (AR), as it is a standalone report from auditors regarding a financial/corporate event, distinct from a full Annual Report (10-K) or an Earnings Release (ER). The reference to specific articles of the French Commercial Code (R. 225-116) confirms its regulatory nature as an auditor's opinion on a transaction. FY 2019
2020-01-03 French
EUROMEDIS : Bilan semestriel contrat de liquidité S2 2019
Capital/Financing Update Classification · 1% confidence The document is titled "Bilan SEMESTRIEL S2 du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont" (Semi-annual Balance Sheet S2 of the liquidity contract...). It details the status and transactions (purchases and sales) related to a liquidity contract for the second half (S2) of 2019, ending on December 31, 2019. It also references the previous semi-annual balance sheet (S1 2019) in an appendix. This type of periodic report detailing the status of a specific financial arrangement (liquidity contract/market making) is characteristic of regulatory filings related to share transactions or capital management, but it is not a standard comprehensive financial report (10-K or IR). Since it is a specific, periodic report detailing share activity under a contract, it most closely aligns with filings related to share transactions or capital structure updates. Given the options, this document reports on the activity of a liquidity contract, which involves the company's own shares being traded by a third party on its behalf. This is a specific type of share transaction reporting. The closest fit among the provided codes is 'Transaction in Own Shares' (POS) or potentially a general 'Regulatory Filing' (RNS). However, since it is a detailed, periodic report on share transactions (buy/sell activity) under a formal agreement, POS is more specific than RNS. It is a report itself, not an announcement of a report, as it contains detailed tables of activity. Therefore, POS is the most appropriate classification.
2020-01-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.